INTRODUCTION
The histo-blood group Lewis antigens comprise Le a and Le b antigens and their antigenic determinants have been determined to be Galfll-~3[Fucal~4]-GlcNAcfl and Fuca 1 ~2Galfl 1 ~3 [ Fuc a 1---,4] GlcNAcfl, respectively (Watkins, 1980) . The Lewis blood group phenotypes have been determined by serological examinations of red blood cells and saliva through hemagglutination tests and hemagglutination inhibition tests using anti-Le a and anti-Le b antibodies. They are grouped as Le(a+b--) and Le(a--b+) (Lewis positive) and Le(a--b--) (Lewis negative) individuals. To date a large number of anti-Lewis monoclonal antibodies have been raised and some of them have been commercially available as is usually the case with monoclonal antibodies against most blood group antigens (Oriol et al., 1990; Good et al., 1992) . However, the Lewis blood group phenoReceived September 11, 1995 ," Revised version accepted November 14, 1995 . * To whom correspondence should be addressed.
types have been typed in error due to the specificities of anti-Le a and anti-Le b antibodies (Yazawa et al., , 1995 . The Lewis blood group phenotypes of red blood cells have been reported to change in pregnancy (Hammer et aL, 1981) , alcoholic cirrhosis and pancreatitis (Stigendal et al., 1984) , hydatid cysts (Makni et aL, 1987) and cancers (Ernst et al., 1984; Limas, 1986; Hirano et aL, 1987; Yazawa et aL, 1988; ~rntoft et al., 1991) . The Lewis blood group antigens could also be found in Lewis-negative individuals (Limas, 1986; ~brntoft et aL, 1991) . In these cases, the genuine Lewis blood types could not be always correctly determined from the serological tests.
Recently, molecular analyses of blood group related genes have been developed (Lutz and Dzik, 1992; Schachter, 1994) , and our previous study on the genomic structures of Le genes from Lewis-positive and Lewis-negative individuals demonstrated that three missence mutations were present in le genes (Nishihara et al., 1994) . The le alleles were divided into two types, lel having the T59 to G and G508 to A mutations, and le2, having the T59 to G and TI067 to A mutations (Nishihara et al., 1994) (Fig. 1 ). In addition, the first mutation (T59 to G) was found to occur unexceptionally in le genes and to become a genetic marker to distinguish between Lewis-positive and Lewis-negative individuals (Nishihara et al., 1993 (Nishihara et al., , 1994 Yazawa et al., 1995) . We have also developed PCR-RFLP methods to detect the aforementioned three missence mutations in le genes (Nishi- Fig. 1 . Schematic comparison of Fuc-TIII nucleotide sequences from Le and le genes and the location of PCR primers. C, TM, SR and CR indicate cytoplasmic tail, transmembrane domain, stem region and catalytic region, respectively, snl, sn2, sn3, sn4, sn5, sn6, sn7, syl and sy2 indicate location of PCR primers used in this study.
hara et al., 1994) . The incompatibility of Lewis phenotypes was observed in patients with cancers (Yazawa et al., 1988) , and the presence of Le enzyme activity in saliva from cancer patients seemed to be consistent with that of Le gene (Yazawa et al., 1988 (Yazawa et al., , 1995 . In order to determine the genuine Lewis blood types of such cancer patients, we analyzed their Lewis genotypes, and found that the patients whose salivas had Le enzyme activity possessed at least one Le gene even though the Lewis phenotypes of their erythrocytes and salivas were Lewis-negative (Yazawa et al., 1995) . In this study, we determined the Lewis genotypes of samples obtained from human hairs and blood stains with the aid of PCR-RFLP methods previously developed and partly modified in this study. We also analyzed, for the first time, the Lewis genotypes of pregnant women with Lewis-negative erythrocytes and of the individuals in the paternity tests to evaluate the usefulness of the present PCR-RFLP methods for the determination of Lewis genotypes.
MATERIALS AND METHODS

Materials
. fucose (85.1 GBq/mmol) and Aquasol-2 were purchased from Du Pont (Boston, MA, U.S.A.). GDP-fucose was from Sigma (St. Louis, MO, U.S.A.). Sep-Pak plt~s C18 reverse-phase cartridges were from Waters (Milford, CT, U.S.A.). Anti-Le a (2DG8) and anti-Le b (TT42) monoclonal antibodies were obtained as described previously . Anti-Le a (lot AU2-070) and anti-Le b (lot LAR-1018) monoclonal antibodies for hemagglutination test and hemagglutination inhibition tests were obtained from Chembiomed (Edmonton, Alberta, Canada). MspI, PvuII, HindIII enzymes, recombinant Taq DNA polymerase and deoxyribonucleoside triphosphates mixture were purchased from Takara (Ohtsu, Japan). Expand Long Template PCR System was from Boehringer Mannheim (Tokyo, Japan). 2'-O-Methyllacto-N-biose I/3Bn was prepared as described previously (Yazawa et al., 1990a) . Freshly plucked hairs from head were obtained from 12 healthy volunteers with different Lewis blood group phenotypes. Blood and salivas were also obtained from healthy individuals and pregnant women.
Genomic DNA. Genomic DNA was prepared from either peripheral blood leukocytes or human hairs and blood specimens by Proteinase K-SDS method (Sabrock et al., 1992) .
Determination of Lewis blood phenotypes and levels of Lewis antigens. Lewis blood phenotypes of samples were determined by a standard test of erythrocytes and saliva, under standard serological techniques (American Association of Blood Banks, 1981) . Serum levels of Le a and Le b antigens were measured by enzyme-linked immunosorbent assay using anti-Le a (2DG8) and anti-Le b (TT42) monoclonal antibodies and expressed in an arbitrary unit (U/ml) by comparison with standard Le a and Le b antigens prepared from human meconium (Yazawa et al., 1990b) (details of the method will be published elsewhere).
Assay of Le enzyme activity. The standard reaction mixture for Le enzyme (al--,3/1-,4fucosyltransferase) assay contained the following components in a final volume of 100/zl: 25/zM GDP-[3H]fucose, 50 mM Tris-HC1 (pH 7.2), 10 mM NAN3, 10 mM MnC12, 5 mM ATP, 10/zl saliva and 50 mM 2"-O-methyllacto-Nbiose I/3Bn. After incubation at 37~ for 5 hr, an equal volume of absolute ethanol was added and the mixture was centrifuged. The enzyme activity of the supernatant was measured by the method described previously using Sep-Pak plus Cz8 (Yazawa et al., 1992) .
PCR-RFLP methods. The PCR primers to obtain the full-length open reading frame of the Fuc-TIII gene (Nishihara et al., 1994) and to detect the mutations are listed in Table 1 . Genomic DNA (---500 ng) was amplified in 50/11 of solution containing snl and sn2 primers (Nishihara et al., 1994) (1 /~M), 200 ~M each dNTP, 50 mM Tris-HC1 (pH 9.2), 14 mM (NH4)2SO4, 2.25 mM MgC12, 2% (v/v) DMSO, 0.1% (v/v) Tween 20 and 2.6 units Taq (Expand Long Template PCR System containing thermostable Taq and Pwo DNA polymerases). Thirty cycles (2 min at 94~ 2 min at 60~ 2 min at 72~ were run to obtain the fulllength open reading frame of the Fuc-TIII gene. The product of the first PCR amplifications was subsequently used for the following PCRs as a template to detect the three missence mutations. To detect the T59G mutation, the first PCR product was then amplified in 50/sl of solution containing sn3 and sn4 primers (1 ,uM), 200 ktM each dNTP, 10 mM Tris-HC1 (pH 8.8), 50 mM KC1, 2.5 mM MgC12, 0.1 mg/ml gelatin and 2.5 units of Taq polymerase. The first cycle (3 min at 94~ 2 min at 62~ and 3 min at 72~ was run, then followed by 39 cycles (1 min at 94~ 1.5 min at 62~ and 1.5 min at 72~
To detect the G508A mutation, the first PCR product was amplified in 50/ll of the same solution except syl and sy2 primers (1 /zM). One cycle (3 min at 93~ and 30 cycles (1 rain at 93~ 1.5 min at 55~ 1.5 min at 72~ and one cycle (5 min at 72~ were run. To detect the T1067A 5'-GCAGGCTCTGGTAGTAGCGCA-3' sn6 60 109 5'-CGCTCCTTCAGCTGGGCACTGGA-3' sn7 5'-CGGCCTCTCAGGTGAACCAAGAAGCT-3' 1 Primers except syl and sy2 were shown in J Biol Chem 269: 29271-29278, 1994. mutation, the first PCR product was amplified in 50,ul of the same solution except sn6 and sn7 (1/zM). Thirty cycles (1 min at 94~ 2 min at 60~ 2 rain at 72~ were run. The second PCR products for detection of T59G, G508A and T1067A mutations were digested by MspI, PvuII and HindIII, respectively, and then analyzed by 1.5% Synergel (BioCraft, Tokyo, Japan)+0.7% agarose gel electrophoresis.
RESULTS AND DISCUSSION
The Fuc-TIII gene is a member of the al-+3fucosyltransferase gene family and determines the expression of Lewis antigens (Kukowska-Latallo et al., 1990) . The genomic structure analyses of Fuc-TIII genes from Le-negative individuals in our previous studies (Nishihara et al., 1993 (Nishihara et al., , 1994 demonstrated that the three missense mutations, i.e., the T59G, the G508A and T1067A were present in le genes. To detect these three mutations found in le genes, PCR-RFLP methods were also developed (Nishihara et al., 1994) and the usefulness of the methods was demonstrated when the genuine Lewis blood types were determined in cancer patients whose salivas contained Le enzyme even though they were phenotyped as Lewis-negative from their erythrocytes (Yazawa et aL, 1995) .
While the methods for Lewis genotyping previously reported were simple, it happened occasionally that the PCR amplification using sn5 and sn2 primers (Nishihara et al., 1994; Yazawa et al., 1995) was incomplete to obtain the 1.4-kbp fragment of Fuc-TIII which was necessary for the analyses of both G508A and T1067A mutations (Nishihara et al., 1994; Yazawa et aL, 1995) . Therefore, we modified the previously reported methods as follows. In order to obtain the adequate amount of the template for second PCRs encompassing positions 59, 508 and 1067, we used the expanded long template PCR system with snl and sn2 primers. Using the first PCR products as the template, the 93-bp PCR fragment was amplified with sn3 and sn4 primers as described in "MATERIALS AND METHODS." As demonstrated previously (Nishihara et al., 1994) , both the artificial change at position 57 of Fuc-TIII sequence from A to C with sn3 primer and T59G mutation created an MspI site, CCGG. The 93-bp PCR fragment was then cleaved into two fragments, 68 and 25 bp (Fig. 2, upper panel) . For the detection of the G508A mutation, we synthesized a new primer set, syl and sy2 (Table 1 ). The syl primer had the sense nucleotide sequence corresponding to the sequence from position 439 to 460 of the Fuc-TIII gene. On the contrary, the sy2 primer had the antisense nucleotide sequence corresponding to the sequence from position 592 to 602. The change at position 508 created a PvuII site, CAGCTG and the 202-bp fragment was then cleaved into two fragments, 131 and 71 bp (Fig. 2, middle was then cleaved into two fragments, 85 and 24 bp by HindIII (Fig. 2, lower panel). The standard PCR-RFLPs to show individual genotypes were prepared using genomic DNAs obtained from peripheral blood leukocytes (Fig. 3) . After Lewis genotyping of more than 100 samples, two individuals having homozygous T1067A missense mutation were found, for the first time, and their genotypes were assigned to le2/le2 (described below).
Twelve saliva samples comprising of 4 Le(a--b+), 4 Le(a+b--) and 4 Le(a--b--) individuals were examined serologically with anti-Le a and anti-Le b antibodies. The activity of a l---,4fucosyltransferase (Le enzyme) was also examined with saliva samples at the same time ( Table 2 ). The genomic DNAs of these 12 individuals were prepared from their hairs and PCR-RFLPs to detect three point mutations in the Le genes were carried out as described above (Fig. 4) and their Lewis genotypes were determined as summarized in the right column of Table 2 . The Lewis-positive individuals whose saliva had Le enzyme activity and Le a and/ or Le b antigen were found to possess at least one Le allele, and their genotypes were Le/Le, Le/lel or Le/le2. On the other hand, the Lewis-negative individuals whose saliva didn't contain Lewis antigen nor Le enzyme activity were found to possess le genes homozygously and their genotypes were lel/lel, lel/le2 or le2/le2 (Table 2) . It was therefore demonstrated that the presence of Lewis antigen and Le enzyme activity was completely consistent with that of the Le gene. Furthermore, the first mutation in the Le gene (T59 to G) was observed unexceptionally in le genes and then seemed to become a genetic marker to distinguish between Lewispositive and Lewis-negative individuals. No individual has been observed who Table 2 . Salivary al-~4fucosyltransferase activity and nucleic acid polymorphisms of Le genes from individuals with blood group Lewis-positive and -negative phenotypes. 
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1 HAI, hemagglutination inhibition; 2 FT, fucosyltransferase, Vol. 41, No. 1, 1996 Fig. 4 . PCR-RFLPs of Le, lel and /e2 genes. PCR-RFLP for detection of the T59G mutation (a), the G508A mutation (b) and T1067A (c) after cleavage of MspI, PvulI and HindIII restriction enzymes, respectively, Gel electrophoresis was done as in Fig. 3 , Lane numbers correspond to samples described in Table 2. had only the T 5 9 G m u t a t i o n w i t h o u t the G 5 0 8 A or the T1067A m u t a t i o n after the Lewis g e n o t y p i n g o f m o r e than 200 specimens (data not shown). Twelve of the 50 pregnant w o m e n showed Lewis-negative erythrocytes. Seven women among them showed the presence of Le g and/or Le b antigen in their plasma inconsistently (Table 3 ). The Lewis blood phenotypes have been reported to change from Lewis-positive to Lewis-negative during pregnancy (Hammer et al., 1981) . It was then supposed that the seven women with Lewis-negative phenotypes whose plasma contained Lewis antigens were Lewis-positive, i.e., Le(a+b--) or Le(a--b+). The Lewis genotyping of these 12 women to detect T59G mutation demonstrated that seven women who had Le a and/or Le b antigen in plasma possessed at least one Le allele (Table 3) . Two women (M.W. and M.Y.) whose saliva were available were found to have Le a antigen and Le b antigen, respectively and Le enzyme activity (data not shown). Recently, we determined the Lewis genotypes of Lewis-negative patients with cancers whose erythrocytes and saliva were found to show inconsistent Lewis phenotypes. The genotyping of their Le genes demonstrated that some of them were non-genuine Lewis-negative and that patients who had Le enzyme activity were genuine Lewis-positive irrespective of their Lewis pheno, types (Yazawa et al., 1995) . These results showed that the Lewis phenotypes from patients with cancer and pregnant women could not provide accurate information regarding the genuine Lewis blood types. However, it was clear that the single PCR-RFLP experiment to detect T59G mutation could be helpful for the determination of the genuine Lewis blood types and, in particular, for distinguishing Lewis-negative individuals from Lewis-positive ones correctly in such cases. More recently, molecular genetic analysis of Se and se genes demonstrated the presence of Se gene (FUT2 gene) encoding al--,2fucosyltransferase which relates to the synthesis of al~2fucosyl residue of H type 1 and Le b antigens in the secretor system Kelly et al., 1995) . It must be possible to determine Le(a--b +) and Le(a + b--) types from sequential genotypings of both the Le and Se genes which encodes the Lewis-dependent a l~4fucosyltransferase demonstrated by us and the secretor-dependent a l-~2fucosyltransferase, respectively. The genotyping of both Le and Se genes, therefore seems to be indispensable to determine genuine Le(a--b-), Le(a+b-) and Le(a--b+) types.
To evaluate the usefulness of the present Lewis genotyping for the paternity test, three cases under examination were picked up and Lewis genotyping of individuals was carried out using their blood stains (Fig. 5) . In case 1, a daughter (A.S.) whose Lewis phenotype was Le(a+b--) possessed lel and Le genes. However, neither the putative father (N.K.) nor the mother (M.S.) possessed lel gene and they were determined to be homozygote of Le genes. Although the Lewis phenotypes of the individuals in this case did not contribute to the test, it was clear that the putative father could be excluded from the candidate of her father from their Lewis genotypings. In cases 2 and 3, each daughter possessed lel (N.G.) and le2 (N.K.) genes, respectively, which probably came from the putative fathers but not from their mothers whose Lewis genotypes were determined to be homozygote of Le genes. In these cases, the putative fathers could not be excluded from the candidate. These results demonstrated that lel, le2 as well as Le genes determined by Lewis genotyping could be useful for the paternity tests and in some cases the Lewis genotyping could provide a conclusive result (as in case 1) which is hard to be obtained from the Lewis phenotyping.
While the conventional determination of Lewis blood types has been carried out mainly by serological examinations using anti-Le a and anti-Le b antibodies, there are problems for Lewis phenotyping with antibodies, in particular, in case when fresh and adequate samples are not available, and it is impossible to determine genuine Lewis blood types of the aforementioned individuals by the conventional analyses.
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~ l e~//l el (~ Le / Le Le(a+b+) Le/lel In conclusion, we demonstrated not only the availability of the newly developed PCR-RFLP methods for Lewis genotypings but also the usefulness of the genotyping of Le genes whose genuine Lewis blood group types were hard to be determined with the conventional methods.
